Evidence map›Paper›PMID 34494880›Full record

ArticlemSphere2021

The Human Gut Resistome up to Extreme Longevity.

Teresa Tavella, Silvia Turroni, Patrizia Brigidi, Marco Candela, Simone Rampelli

Abstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Resistome in the indoor dust samples from workplaces and households: a pilot study.Frontiers in cellular and infection microbiology · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Teresa Tavella *Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bolognagrid.6292.f, Bologna, Italy.
Silvia Turroni *Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bolognagrid.6292.f, Bologna, Italy.ORCID 0000-0003-2345-9482
Patrizia BrigidiDepartment of Medical and Surgical Sciences, University of Bolognagrid.6292.f, Bologna, Italy.
Marco CandelaUnit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bolognagrid.6292.f, Bologna, Italy.
Simone RampelliUnit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bolognagrid.6292.f, Bologna, Italy.ORCID 0000-0002-5655-6695

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance (AR) is indisputably a major health threat which has drawn much attention in recent years. In particular, the gut microbiome has been shown to act as a pool of AR genes, potentially available to be transferred to opportunistic pathogens. Herein, we investigated for the first time changes in the human gut resistome during aging, up to extreme longevity, by analyzing shotgun metagenomics data of fecal samples from a geographically defined cohort of 62 urban individuals, stratified into four age groups: young adults, elderly, centenarians, and semisupercentenarians, i.e., individuals aged up to 109 years. According to our findings, some AR genes are similarly represented in all subjects regardless of age, potentially forming part of the core resistome. Interestingly, aging was found to be associated with a higher burden of some AR genes, including especially proteobacterial genes encoding multidrug efflux pumps. Our results warn of possible health implications and pave the way for further investigations aimed at containing AR accumulation, with the ultimate goal of promoting healthy aging.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsBacteriaCentenariansCohort StudiesDrug Resistance, MicrobialFecesFemaleGastrointestinal MicrobiomeGastrointestinal TractHumansLongevityMaleMetagenomicsAnti-Bacterial Agentsagingantibiotic resistanceextreme longevitymetagenomemicrobiomeresistome

Identifiers

PMID34494880
PMCPMC8550338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.